Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Clinical trial NCT03677401 · COMPLETED
Trial details
- NCT number
- NCT03677401
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2020-01-09
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.